pancreatic cancer Mar 2, 2023 Gritstone Bio, NCI Aim to Boost Tumor Immune Responses With KRAS-Targeted Vaccine, Cell Therapy Premium Mar 1, 2023 Biological Dynamics, OHSU Partner to Validate Pancreatic Cancer Early Detection Test Feb 27, 2023 Monopar Therapeutics, NorthStar Medical Radioisotopes Partner on Radiopharmaceutical Trial Jan 31, 2023 NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test Jan 25, 2023 Dana-Farber Tracks Impact of Precision Oncology Decision Support Program for GI Cancer Patients Premium Jan 20, 2023 Mirati Therapeutics' KRAS G12D Inhibitor Cleared by FDA to Begin Phase I/II Trial Jan 18, 2023 Penn Scientists Testing Out CAR T-Cell Therapy Gel to Prevent Breast Cancer Recurrence Post-Surgery Premium Jan 17, 2023 Yantai LNC Biotechnology to Use Sofie Biosciences Imaging Agent to ID Patients for Theranostic Trial Jan 17, 2023 Lantern Pharma Preparing IND for Synthetic Lethality Program With FDA Feedback Jan 11, 2023 Bio4t2 Begins Dosing Solid Tumor Patients in First-In-Human CAR T-Cell Therapy Trial Jan 10, 2023 Immunocore Unveils New T-Cell Receptor Therapy Candidates, Estimates $140M in 2022 Kimmtrak Sales Dec 6, 2022 Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients Dec 1, 2022 Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Nov 29, 2022 Alaunos Therapeutics Expecting $15.7M in Common Stock Offering Nov 23, 2022 Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test Oct 27, 2022 Immunotherapy Response Features Identified in Pancreatic Cancer Microenvironment Oct 21, 2022 Erasca to Study ERK Inhibitor With Pfizer's Ibrance in Tumors Harboring KRAS, NRAS Mutations Oct 12, 2022 Genetic Testing Challenges in Oncology: Missed Variant Update Delays Li-Fraumeni Diagnosis Oct 7, 2022 Swiss Biotech PreComb Therapeutics Wants to Automate Functional Precision Medicine Premium Oct 5, 2022 Genomic Test IDs Pancreatic Cysts Likely to Progress to Cancer Better Than Standard Guidelines Premium Load More Breaking News Flare Therapeutics Raises $123M in Oversubscribed Series B Funding Round William Blair Initiates Coverage of MDxHealth With Outperform Rating White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development In Brief This Week: Fore Biotherapeutics, RayzeBio, Gilead Sciences, Atossa Therapeutics Bayer to Assess Nubeqa in High-Risk, Early-Stage Hormone-Sensitive Prostate Cancer BridgeBio Begins Phase I/II Study of SHP2 Inhibitor, Opdivo in KRAS-Mutant Solid Tumors
